New BSAVA manual revealed
The third edition of the manual offers deeper insight into a wider range of conditions
Early detection of chronic kidney disease and the genetic basis for urinary tract disease are just two of the new topics covered in the latest edition of the BSAVA Manual of Canine and Feline Nephrology and Urology. The third edition of this latest practical guide sees Jodi Westropp join previous editors Jonathan Elliott and Greg Grauer to complete an experienced editorial panel, offering deeper insight into an even wider range of conditions.
In the 10 years since the second edition, many new technologies have been developed and employed in this area, and the new manual reflects their impacts on the understanding, diagnosis and treatment of urinary tract disorders.
This latest edition covers common presenting clinical and laboratory problems, therapeutic techniques, and the clinical management of important disease syndromes. New chapters have been added, including early detection of chronic kidney disease, assessment of calcium and phosphate homeostasis, and those considering the effects of systemic diseases that complicate the management of kidney disease.
Chapters from the previous edition have been updated to reflect common consensus, and case examples, comprehensive reference tables and flowcharts are included for ease of reference.
“A fresh look has been taken at many of the tried-and-tested chapters by inviting new authors to provide their perspectives on these familiar topics,” says Jonathon Elliott. “The number of clinical experts from Europe and the United States who are actively publishing original clinical research papers in nephrology and urology has grown in recent years, so we have had no difficulty in identifying new truly international experts as authors.”
The third edition of the BSAVA Manual of Canine and Feline Nephrology and Urology is available now via the BSAVA website or telephone 01452 726700.
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
